This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jeongmin Joo: Innovator in Cancer Treatment
Introduction
Jeongmin Joo is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work has the potential to impact cancer therapies positively.
Latest Patents
Jeongmin Joo holds a patent for a Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer. This invention includes a compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof. The compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), making it a promising candidate for cancer treatment.
Career Highlights
Jeongmin Joo is associated with Omic Smap Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on improving therapeutic options for cancer patients.
Collaborations
Some of his notable coworkers include Jung Jin Hwang and Sang Eun Park. Their collaborative efforts contribute to the ongoing research and development initiatives at Omic Smap Inc.
Conclusion
Jeongmin Joo's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work exemplifies the potential of scientific advancements to improve health outcomes for patients.